Physician

Oliver Shu-On Tai, MD

According to 2025 Medicare claims, Oliver Tai, MD (NPI: 1699885731) practices nephrology in the Everett, WA market, with the plurality of this provider's patient population coming from Snohomish, WA. This provider's primary affiliated billing organization is SNOKIDNEY PLLC (NPI: 1528810843; TIN: 992175183) and primary practice location at 98206-1665.

Tai's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 382 traditional Medicare patients, billed 2,151 HCPCS/CPT codes, and received $173,309 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,801 prescription claims across 436 beneficiaries totaling $951,207 in drug costs, led by Jardiance (Empagliflozin). DME data shows 316 claims. Open Payments data shows 6 records totaling $228. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $312,459 to $951,207. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	380	3,568	$181,635
2016	303	3,644	$167,872
2017	334	4,953	$177,095
2018	321	2,740	$165,899
2019	314	1,315	$154,157
2020	320	1,296	$149,204
2021	326	1,351	$176,490
2022	301	1,200	$149,320
2023	301	1,256	$142,180
2024	382	2,151	$173,309

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	410	3,654	$312,459
2016	345	3,581	$434,155
2017	375	3,650	$617,592
2018	354	3,012	$338,439
2019	324	2,594	$235,065
2020	298	2,806	$188,262
2021	302	2,754	$433,307
2022	333	3,385	$803,117
2023	370	3,517	$877,448
2024	436	3,801	$951,207

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	282	$14,806
2016	40	482	$21,995
2017	39	515	$19,757
2018	40	501	$17,463
2019	53	709	$25,060
2020	54	775	$28,065
2021	49	712	$22,329
2022	46	575	$18,129
2023	26	502	$16,733
2024	N/R	316	$5,980

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	132	217	$77
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	82	341	$61
99457	Management using the results of remote vital sign monitoring per calendar month, first 20 minutes	80	113	$39
99458	Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes	75	185	$31
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	141	237	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jardiance	Empagliflozin	381	27,272	$437,345
Farxiga	Dapagliflozin Propanediol	136	9,550	$173,599
Ozempic	Semaglutide	90	3,854	$123,173
Cinacalcet Hcl	Cinacalcet Hcl	42	2,986	$23,526
Sevelamer Carbonate	Sevelamer Carbonate	67	4,364	$17,072

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7515	Cyclosporine, oral, 25 mg	N	N/R	20	$2,253
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	90	$1,116
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	61	$997
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	79	$672
J7518	Mycophenolic acid, oral, 180 mg	N	N/R	16	$589

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$228	Baxter Healthcare
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Oliver Shu-On Tai, MD?

Tedicare shows public-source Medicare data for Oliver Shu-On Tai, MD (NPI 1699885731), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Oliver Shu-On Tai, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Oliver Shu-On Tai, MD?

Oliver Shu-On Tai, MD is linked to SNOKIDNEY PLLC (billing NPI 1528810843) in the available physician profile data.

Does Oliver Shu-On Tai, MD have Open Payments data?

Oliver Shu-On Tai, MD has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.